Donovan Michael Glancy's most recent trade in Collegium Pharmaceutical Inc was a trade of 17,482 Common Stock done . Disclosure was reported to the exchange on May 14, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Collegium pharma Inc | Donovan Michael Glancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2026 | 17,482 | 17,482 (0%) | 0% | 0 | Common Stock |